Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...
The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback